Metropolis Healthcare on Monday said its unit will acquire Agra-based Scientific Pathology for up to Rs 83 crore. Metropolis Clinical Pathology, a wholly-owned subsidiary of the diagnostics firm, has inked a business transfer agreement with Scientific Pathology.
The strategic move strengthens Metropolis' presence in Western Uttar Pradesh, accelerates its B2C expansion, and unlocks growth opportunities across the state and beyond, the company said in a statement.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Under the agreement, Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
The consideration for the acquisition will range between Rs 55 crore and Rs 83 crore, determined at 12.2x of the adjusted Ebitda over a defined assessment period, Metropolis stated.
The transaction will be executed through a Securities Subscription Cum Shareholders' Agreement (SHA), backed by Metropolis Healthcare, it added.
"Scientific Pathology's strong B2C focus and 40-year legacy align seamlessly with our vision to lead in these markets," Ameera Shah, promoter and Executive Chairperson, Metropolis Healthcare, stated.
With an estimated market size of Rs 2,000 crore, Uttar Pradesh is one of North India's fastest-growing diagnostic markets.
"We look forward to a seamless integration that enhances healthcare access and benefits patients, doctors, and healthcare providers across Western Uttar Pradesh," Scientific Pathology Founder Ashok Kumar Sharma said.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
